The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

On day 2 of an FDA advisory meeting to consider a new treatment for non–muscle invasive bladder cancer, an FDA official warns ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first ...

the Food and Drug Administration has approved the first ever at-home cervical cancer screening kit. On Friday, May 9, the FDA approved the Teal Wand, an at-home vaginal sample self-collection ...

Verastem Oncology said the Food and Drug Administration approved the combination of avutometinib capsules and defactinib tablets for certain patients with KRAS-mutated recurrent low-grade serous ...

The first at-home cervical cancer screening test has been approved by the Food and Drug Administration, according to the ...

Accelerated approval was based on the Phase 2 RAMP 201 study that demonstrated a 44% overall response rate in patients with KRAS-mutated recurrent low-grade serous ovarian cancer, the company said.